Bridgefront Capital’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,954
| Closed | -$51.2K | – | 583 |
|
|
2024
Q2 | $51.2K | Buy |
+10,954
| New | +$51.2K | 0.02% | 465 |
|
|
2023
Q3 | – | Sell |
-53,320
| Closed | -$439K | – | 445 |
|
|
2023
Q2 | $439K | Buy |
53,320
+22,601
| +74% | +$186K | 0.24% | 146 |
|
|
2023
Q1 | $223K | Buy |
+30,719
| New | +$223K | 0.14% | 307 |
|
|
2021
Q2 | – | Sell |
-6,554
| Closed | -$275K | – | 672 |
|
|
2021
Q1 | $275K | Buy |
6,554
+732
| +13% | +$30.7K | 0.09% | 458 |
|
|
2020
Q4 | $408K | Buy |
+5,822
| New | +$408K | 0.14% | 273 |
|